These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15857550)

  • 1. Alternative outcome measures for pediatric clinical sepsis trials.
    Curley MA; Zimmerman JJ
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S150-6. PubMed ID: 15857550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.
    Odetola FO; Gebremariam A; Freed GL
    Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the role of neonatal organ dysfunction and illness severity scores in therapeutic studies in sepsis?
    Tarnow-Mordi WO
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S135-7. PubMed ID: 15857546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome.
    Tamburro R
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S87-91. PubMed ID: 15857565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers as end points in clinical trials of severe sepsis: a garden of forking paths.
    Salluh JI; Póvoa P
    Crit Care Med; 2010 Aug; 38(8):1749-51. PubMed ID: 20647805
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.
    Powers JH
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):109S-123S. PubMed ID: 16305280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of the results of clinical trials: surrogate end points and composite end points.
    Gensini GF; Conti AA
    Minerva Med; 2004 Feb; 95(1):71-5. PubMed ID: 15041928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
    Ospina-Tascón GA; Büchele GL; Vincent JL
    Crit Care Med; 2008 Apr; 36(4):1311-22. PubMed ID: 18379260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of statin therapy in sepsis.
    Chua D; Tsang RS; Kuo IF
    Ann Pharmacother; 2007 Apr; 41(4):647-52. PubMed ID: 17389664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin therapy in the pediatric intensive care unit.
    Verbruggen SC; Joosten KF; Castillo L; van Goudoever JB
    Clin Nutr; 2007 Dec; 26(6):677-90. PubMed ID: 17950500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation committees: the time is right but is the timing right?
    Teplick R
    Crit Care Med; 2003 Sep; 31(9):2403-5. PubMed ID: 14501976
    [No Abstract]   [Full Text] [Related]  

  • 14. Sepsis and its complications: the clinical problem.
    Bone RC
    Crit Care Med; 1994 Jul; 22(7):S8-11. PubMed ID: 8026190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of critical care.
    LaRovere JM; Jeffries HE; Sachdeva RC; Rice TB; Wetzel RC; Cooper DS; Bird GL; Ghanayem NS; Checchia PA; Chang AC; Wessel DL
    Cardiol Young; 2008 Dec; 18 Suppl 2():130-6. PubMed ID: 19063783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What have we learned about randomized, controlled trials in neonatal sepsis?
    Tarnow-Mordi WO
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S146-9. PubMed ID: 15857549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interhospital transfer on resource utilization and outcomes at a tertiary pediatric intensive care unit.
    Odetola FO; Clark SJ; Gurney JG; Dechert RE; Shanley TP; Freed GL
    J Crit Care; 2009 Sep; 24(3):379-86. PubMed ID: 19327327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite outcomes in clinical trials: uses and problems.
    Carneiro AV
    Rev Port Cardiol; 2003 Oct; 22(10):1253-63. PubMed ID: 14708338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
    Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
    Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.